Startup list · Global
Longevity startups
Below are the top global longevity startups, ranked by total funding. Together the 50 companies on this list have raised a combined $19B, and include 14 unicorns. The strongest hubs are United States, United Kingdom, Switzerland.
$19Bcombined funding · 50 companies
United Statestop hub
50companies shown
14unicorns
Ranked by total funding · Updated 2026-10-30 · Source: Dealroom
| # | Company | Founded | HQ | Funding |
|---|---|---|---|---|
| 1 |
 A
Altos LabsUnicorn
Biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming
|
2021 | Redwood City, United States | $3.3B |
| 2 |
 F
FreenomeUnicorn
A health technology company developing accurate, accessible and non-invasive disease screening products
|
2014 | Brisbane, United States | $1.4B |
| 3 |
 Ō
ŌURAUnicorn
An award-winning and fast-growing startup that helps people track all stages of sleep and activity
|
2013 | Oulu, Finland | $1.3B |
| 4 |
 N
Neko HealthUnicorn
Preventive full-body health scans with proprietary sensors and clinician review
|
2018 | Stockholms kommun, Sweden | $1.2B |
| 5 |
 R
Retro BiosciencesUnicorn
Cellular reprogramming, autophagy, & plasma-inspired therapeutics
|
2020 | Redwood City, United States | $1.2B |
| 6 |
 S
SomaLogicUnicorn
Unlocking protein biomarkers to transform healthcare
|
2000 | Boulder, United States | $832M |
| 7 |
 F
Function HealthUnicorn
Offers 100+ lab tests with expert insights and secure tracking for comprehensive health assessments
|
2022 | Austin, United States | $804M |
| 8 |
 B
Biosplice TherapeuticsUnicorn
Medical research and development for tissue-level regeneration
|
2008 | San Diego, United States | $778M |
| 9 |
 N
NewLimitUnicorn
Epigenetic reprogramming medicines to treat age-related disease
|
2021 | South San Francisco, United States | $650M |
| 10 |
 I
InSilico MedicineUnicorn
Develops an AI platform for drug development to treat cancer and age-related diseases
|
2014 | Cambridge, United States | $532M |
| 11 |
 V
Verdiva BioUnicorn
Oral therapies for obesity and cardiometabolic disorders
|
2025 | London, United Kingdom | $411M |
| 12 |
 H
Human Longevity
A genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived
|
2013 | San Diego, United States | $360M |
| 13 |
 J
Juvenescence
We're a clinical-stage AI-enabled biotech company developing novel medicines to extend healthy lifespan.
|
2016 | Dublin, Ireland | $341M |
| 14 |
 B
Biolinq
Develops skin-applied electrochemical sensors that analyze body fluids to provide actionable health information
|
2012 | San Diego, United States | $313M |
| 15 |
 O
Orchard TherapeuticsUnicorn
Hematopoietic stem cell gene therapies for rare diseases
|
2015 | London, United Kingdom | $308M |
| 16 |
 E
Endeavor BioMedicines
Clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis
|
2018 | San Diego, United States | $296M |
| 17 |
 B
BioAge Labs
BIOAGE discovers and develops drugs to treat aging and associated diseases
|
2015 | Emeryville, United States | $294M |
| 18 |
 G
Gyroscope TherapeuticsUnicorn
Developing one-time gene therapies for retinal diseases
|
2016 | London, United Kingdom | $275M |
| 19 |
 L
Life Biosciences
working on different ways to tackle age-related diseases with a view to ultimately extending healthy life spans
|
2017 | Boston, United States | $255M |
| 20 |
 L
Loyal
Developing drugs intended to extend the healthspan and lifespan of dogs
|
2019 | San Francisco, United States | $218M |
| 21 |
 U
Unity Biotechnology
Creating therapeutics that prevent, halt, or reverse numerous diseases of aging
|
2009 | South San Francisco, United States | $211M |
| 22 |
 V
Viome$25M+ revenue
Provides the industry’s only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA)
|
2016 | Bellevue, United States | $211M |
| 23 |
 B
Biomodal
Simultaneous genetic and epigenetic sequencing from single samples
|
2012 | Cambridge, United Kingdom | $185M |
| 24 |
 P
Prenuvo
Offers advanced whole-body MRI scans for early detection of cancer and other diseases, aiming to shift healthcare from reactive to proactive
|
2018 | Redwood City, United States | $176M |
| 25 |
 Z
Zealand PharmaUnicorn
Discovery, design and development of innovative peptide-based medicines
|
1998 | Søborg, Denmark | $165M |
| 26 |
 V
Vivoryon TherapeuticsDealroom profile unavailable
Biopharmaceutical company focused on the development of innovative small molecule drugs
|
1997 | Halle (Saale), Germany | $162M |
| 27 |
 C
Cambrian BioPharma
Biotechnology company developing transformative medicines for aging-related diseases
|
2019 | New York City, United States | $160M |
| 28 |
 A
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals is a research stage biopharmaceutical company aiming to discover, develop and commercialize innovative therapeutics for the treatment of rare and age-related diseases
|
2012 | Berkeley, United States | $142M |
| 29 |
 R
Resolution Therapeutics
Macrophage cell therapies for inflammatory organ diseases
|
2017 | Edinburgh, United Kingdom | $132M |
| 30 |
 L
L-nutra
Nutri-technology company, spearheading longevity science nutrition programs
|
2009 | Los Angeles, United States | $131M |
| 31 |
 C
Corsera HealthFast growing
AI-powered cardiovascular disease prediction and RNAi prevention
|
2024 | Boston, United States | $130M |
| 32 |
 A
Asceneuron
Develops effective therapeutics for orphan tauopathies
|
2012 | Lausanne, Switzerland | $130M |
| 33 |
 P
Parsley Health$25M+ revenue
Next generation medical advice from doctors
|
2016 | New York City, United States | $121M |
| 34 |
 E
Entact Bio
A preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins
|
2019 | Watertown, United States | $121M |
| 35 |
 S
Seven Bridges
A cloud-based environment for conducting bioinformatic analyses
|
2009 | New Belgrade Urban Municipality, Serbia | $119M |
| 36 |
 F
Fountain Life
Providing an innovative, fully integrated platform delivering best-in-class predictive, preventative, personalized, and data-driven health
|
2019 | Orlando, United States | $100M |
| 37 |
 A
Addex Therapeutics
Discovers and develops small molecule oral drugs to treat a range of medical conditions
|
2001 | Geneva, Switzerland | $100M |
| 38 |
 S
Stealth BioTherapeuticsDealroom profile unavailable
Developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging
|
2007 | Needham, United States | $100M |
| 39 |
 C
Centenara Labs
Creating therapies to improve healthy aging, based on experienced drug discovery
|
2019 | Schlieren, Switzerland | $99M |
| 40 |
 E
Elixir Pharmaceuticals
Elixir Pharmaceuticals develops and commercializes pharmaceuticals for the treatment of metabolic diseases
|
1999 | Cambridge, United States | $99M |
| 41 |
 A
AviadoBio
Precision gene therapies for neurodegenerative disorders
|
2019 | London, United Kingdom | $96M |
| 42 |
 N
NightStar Therapeutics
AAV gene therapies for inherited retinal diseases
|
2014 | London, United Kingdom | $96M |
| 43 |
 A
Antag Therapeutics
Antag Therapeutics – Therapeutic peptides for the treatment of obesity
|
2017 | Copenhagen, Denmark | $94M |
| 44 |
 E
Engitix
ECM-based drug discovery for cancer and fibrosis.
|
2016 | London, United Kingdom | $86M |
| 45 |
 C
Complement Therapeutics
Gene therapy for complement-mediated diseases and blindness
|
2020 | London, United Kingdom | $85M |
| 46 |
 T
TreeFrog Therapeutics
Stem cell company that will enable millions of patients to access the medical revolution of cell
|
2018 | Pessac, France | $83M |
| 47 |
 S
Sirtris Pharmaceuticals
Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases
|
2004 | Cambridge, United States | $82M |
| 48 |
 M
Muna Therapeutics
Discovering and developing transformative therapeutics for neurodegenerative diseases
|
2020 | Copenhagen, Denmark | $79M |
| 49 |
 T
Timeline
Science-based longevity products targeting cellular aging
|
2007 | Lausanne, Switzerland | $75M |
| 50 |
 V
Voy
Aims to improve the daily lives of men by encouraging men to take control of their happiness and health and talk openly
|
2018 | London, United Kingdom | $73M |
Track longevity startups worldwide
Get the full dataset — funding rounds, investors, signals and new entrants — in the Dealroom platform.
Book a demo